Luke Taylor: Covid-19: Is Manaus the final nail in the coffin for natural herd immunity? In: BMJ. 12. Februar 2021, ISSN1756-1833, S.n394, doi:10.1136/bmj.n394 (bmj.com [abgerufen am 23. Februar 2021]).
L. Gordis: Epidemiology. Elsevier Health Sciences, 2013, ISBN 978-1-4557-4251-6, S.26–27 (google.com [abgerufen am 29. März 2015]).
D. Rakel, R. E. Rakel: Textbook of Family Medicine. Elsevier Health Sciences, 2015, ISBN 978-0-323-31308-7, S.99, 187 (google.com [abgerufen am 30. März 2015]).
T. H. Tulchinsky, E. A. Varavikova: The New Public Health: An Introduction for the 21st Century. Academic Press, 2014, ISBN 978-0-12-415767-5, S.163–182 (google.com [abgerufen am 30. März 2015]).
E. Fukuda, J. Tanimoto: Impact of Stubborn Individuals on a Spread of Infectious Disease under Voluntary Vaccination Policy. Springer, 2014, ISBN 978-3-319-13359-1, S.1–10 (google.com [abgerufen am 30. März 2015]).
John T. Jacob, Samuel Reuben: Herd immunity and herd effect: new insights and definitions. In: Eur J Epidemiol., 2000, 16(7), S. 601–606, doi:10.1023/a:1007626510002, JSTOR:3582376
A. McGirr, D. N. Fisman: Duration of pertussis immunity after DTaP immunization: a meta-analysis. In: Pediatrics. Band 135, Nummer 2, Februar 2015, S. 331–343, doi:10.1542/peds.2014-1729, PMID 25560446.
Patsarin Rodpothong, Prasert Auewarakul: Viral evolution and transmission effectiveness. In: World Journal of Virology. Band1, Nr.5, 12. Oktober 2012, S.131–134, doi:10.5501/wjv.v1.i5.131.
Davide Corti, Antonio Lanzavecchia: Broadly Neutralizing Antiviral Antibodies. In: Annual Review of Immunology. Band31, Nr.1, 21. März 2013, S.705–742, doi:10.1146/annurev-immunol-032712-095916.
Rowena A. Bull, Peter A. White: Mechanisms of GII.4 norovirus evolution. In: Trends in Microbiology. Band19, Nr.5, Mai 2011, ISSN0966-842X, S.233–240, doi:10.1016/j.tim.2011.01.002.
Sasirekha Ramani et al.: Epidemiology of human noroviruses and updates on vaccine development. In: Current Opinion in Gastroenterology. Band30, Nr.1, Januar 2014, S.25–33, doi:10.1097/MOG.0000000000000022.
S. Cesaro, M. Giacchino, F. Fioredda, A. Barone, L. Battisti, S. Bezzio, S. Frenos, R. De Santis, S. Livadiotti, S. Marinello, A. G. Zanazzo, D. Caselli: Guidelines on vaccinations in paediatric haematology and oncology patients. In: BioMed research international. Band 2014, 2014, S. 707691, doi:10.1155/2014/707691, PMID 24868544, PMC 4020520 (freier Volltext)
R. M. Wolfe: Update on adult immunizations. In: Journal of the American Board of Family Medicine: JABFM. Band 25, Nummer 4, 2012 Jul-Aug, S. 496–510, doi:10.3122/jabfm.2012.04.100274, PMID 22773718
S. Esposito, S. Bosis, L. Morlacchi, E. Baggi, C. Sabatini, N. Principi: Can infants be protected by means of maternal vaccination? In: Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. Band 18 Suppl 5, Oktober 2012, S. 85–92, doi:10.1111/j.1469-0691.2012.03936.x, PMID 22862749
T. H. Kim, J. Johnstone, M. Loeb: Vaccine herd effect. In: Scandinavian journal of infectious diseases. Band 43, Nummer 9, September 2011, S. 683–689, doi:10.3109/00365548.2011.582247, PMID 21604922, PMC 3171704 (freier Volltext).
L. F. Pittet, K. M. Posfay-Barbe: Pneumococcal vaccines for children: A global public health priority. In: Clinical Microbiology and Infection. 18 Suppl 5. Jahrgang, 2012, S.25–36, doi:10.1111/j.1469-0691.2012.03938.x, PMID 22862432.
O. Nakagomi, M. Iturriza-Gomara, T. Nakagomi, N. A. Cunliffe: Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: A review. In: Expert Opinion on Biological Therapy. 13. Jahrgang, Nr.11, 2013, S.1613–1621, doi:10.1517/14712598.2013.840285, PMID 24088009.
B. A. Lopman, D. C. Payne, J. E. Tate, M. M. Patel, M. M. Cortese, U. D. Parashar: Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. In: Current Opinion in Virology. 2. Jahrgang, Nr.4, 2012, S.434–442, doi:10.1016/j.coviro.2012.05.002, PMID 22749491 (zenodo.org).
T. H. Kim: Seasonal influenza and vaccine herd effect. In: Clinical and Experimental Vaccine Research. 3. Jahrgang, Nr.2, 2014, S.128–132, doi:10.7774/cevr.2014.3.2.128, PMID 25003085, PMC 4083064 (freier Volltext).
A. Lenzi, V. Mirone, V. Gentile, R. Bartoletti, V. Ficarra, C. Foresta, L. Mariani, S. Mazzoli, S. G. Parisi, A. Perino, M. Picardo, C. M. Zotti: Rome Consensus Conference – statement; human papilloma virus diseases in males. In: BMC Public Health. 13. Jahrgang, 2013, S.117, doi:10.1186/1471-2458-13-117, PMID 23391351, PMC 3642007 (freier Volltext).
S. M. Garland, S. R. Skinner, J. M. Brotherton: Adolescent and young adult HPV vaccination in Australia: Achievements and challenges. In: Preventive Medicine. 53 Suppl 1. Jahrgang, 2011, S.S29–35, doi:10.1016/j.ypmed.2011.08.015, PMID 21962468.
F. Njeumi, W. Taylor, A. Diallo, K. Miyagishima, P. P. Pastoret, B. Vallat, M. Traore: The long journey: a brief review of the eradication of rinderpest. In: Revue scientifique et technique. Band 31, Nummer 3, Dezember 2012, S. 729–746, doi:10.20506/rst.31.3.2157, PMID 23520729.
Maia Martcheva u. a.: Vaccine-induced pathogen strain replacement: what are the mechanisms? In: J R Soc Interface, 2008 Jan 6, 5(18), S. 3–13, doi:10.1098/rsif.2007.0236, PMID 17459810, PMC 2405901 (freier Volltext)
Romesa Ibrahim u. a.: Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting. In: Vaccine, 2018 Nov 12; 36(46), S. 7048–7053, doi:10.1016/j.vaccine.2018.09.045, PMID 30297122, PMC 6219892 (freier Volltext)
J. Logan, D. Nederhoff, B. Koch, B. Griffith, J. Wolfson, F. A. Awan, N. E. Basta: What have you HEARD about the HERD? Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate? In: Vaccine. Band 36, Nummer 28, 06 2018, S. 4118–4125, doi:10.1016/j.vaccine.2018.05.037, PMID 29789242, PMC 6008254 (freier Volltext).
A. Perisic, C. T. Bauch: Social contact networks and disease eradicability under voluntary vaccination. In: PLoS Computational Biology. 5. Jahrgang, Nr.2, 2009, S.e1000280, doi:10.1371/journal.pcbi.1000280, PMID 19197342, PMC 2625434 (freier Volltext).
F. Fu, D. I. Rosenbloom, L. Wang, M. A. Nowak: Imitation dynamics of vaccination behaviour on social networks. In: Proceedings of the Royal Society B: Biological Sciences. 278. Jahrgang, Nr.1702, 2011, S.42–49, doi:10.1098/rspb.2010.1107, PMID 20667876, PMC 2992723 (freier Volltext) – (harvard.edu [PDF]).
S. Wicker, H. C. Maltezou: Vaccine-preventable diseases in Europe: Where do we stand? In: Expert Review of Vaccines. 13. Jahrgang, Nr.8, 2014, S.979–987, doi:10.1586/14760584.2014.933077, PMID 24958075.
Nisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, Rupert Beale, Nahid Bhadelia: Scientific consensus on the COVID-19 pandemic: we need to act now. In: The Lancet. Band396, Nr.10260, Oktober 2020, ISSN0140-6736, doi:10.1016/s0140-6736(20)32153-x, PMID 33069277, PMC 7557300 (freier Volltext).
Christie Aschwanden: The false promise of herd immunity for COVID-19. In: Nature. Band587, Nr.7832, 21. Oktober 2020, S.26–28, doi:10.1038/d41586-020-02948-4.
Luke Taylor: Covid-19: Is Manaus the final nail in the coffin for natural herd immunity? In: BMJ. 12. Februar 2021, ISSN1756-1833, S.n394, doi:10.1136/bmj.n394 (bmj.com [abgerufen am 23. Februar 2021]).
Jennifer Juno, Adam Wheatley: Mounting evidence suggests COVID vaccines do reduce transmission. How does this work?Gavi, 11. Mai 2021 (“… immunisation with either the Pfizer or AstraZeneca vaccine reduced the chance of onward virus transmission by 40–60 %. This means that if someone became infected after being vaccinated, they were only around half as likely to pass their infection on to others compared to infected people who weren’t vaccinated.”)
harvard.edu
dash.harvard.edu
F. Fu, D. I. Rosenbloom, L. Wang, M. A. Nowak: Imitation dynamics of vaccination behaviour on social networks. In: Proceedings of the Royal Society B: Biological Sciences. 278. Jahrgang, Nr.1702, 2011, S.42–49, doi:10.1098/rspb.2010.1107, PMID 20667876, PMC 2992723 (freier Volltext) – (harvard.edu [PDF]).
John T. Jacob, Samuel Reuben: Herd immunity and herd effect: new insights and definitions. In: Eur J Epidemiol., 2000, 16(7), S. 601–606, doi:10.1023/a:1007626510002, JSTOR:3582376
A. McGirr, D. N. Fisman: Duration of pertussis immunity after DTaP immunization: a meta-analysis. In: Pediatrics. Band 135, Nummer 2, Februar 2015, S. 331–343, doi:10.1542/peds.2014-1729, PMID 25560446.
S. Cesaro, M. Giacchino, F. Fioredda, A. Barone, L. Battisti, S. Bezzio, S. Frenos, R. De Santis, S. Livadiotti, S. Marinello, A. G. Zanazzo, D. Caselli: Guidelines on vaccinations in paediatric haematology and oncology patients. In: BioMed research international. Band 2014, 2014, S. 707691, doi:10.1155/2014/707691, PMID 24868544, PMC 4020520 (freier Volltext)
R. M. Wolfe: Update on adult immunizations. In: Journal of the American Board of Family Medicine: JABFM. Band 25, Nummer 4, 2012 Jul-Aug, S. 496–510, doi:10.3122/jabfm.2012.04.100274, PMID 22773718
S. Esposito, S. Bosis, L. Morlacchi, E. Baggi, C. Sabatini, N. Principi: Can infants be protected by means of maternal vaccination? In: Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. Band 18 Suppl 5, Oktober 2012, S. 85–92, doi:10.1111/j.1469-0691.2012.03936.x, PMID 22862749
General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). In: MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports. Band 60, Nummer 2, Januar 2011, S. 1–64, PMID 21293327.
T. H. Kim, J. Johnstone, M. Loeb: Vaccine herd effect. In: Scandinavian journal of infectious diseases. Band 43, Nummer 9, September 2011, S. 683–689, doi:10.3109/00365548.2011.582247, PMID 21604922, PMC 3171704 (freier Volltext).
L. F. Pittet, K. M. Posfay-Barbe: Pneumococcal vaccines for children: A global public health priority. In: Clinical Microbiology and Infection. 18 Suppl 5. Jahrgang, 2012, S.25–36, doi:10.1111/j.1469-0691.2012.03938.x, PMID 22862432.
O. Nakagomi, M. Iturriza-Gomara, T. Nakagomi, N. A. Cunliffe: Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: A review. In: Expert Opinion on Biological Therapy. 13. Jahrgang, Nr.11, 2013, S.1613–1621, doi:10.1517/14712598.2013.840285, PMID 24088009.
B. A. Lopman, D. C. Payne, J. E. Tate, M. M. Patel, M. M. Cortese, U. D. Parashar: Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. In: Current Opinion in Virology. 2. Jahrgang, Nr.4, 2012, S.434–442, doi:10.1016/j.coviro.2012.05.002, PMID 22749491 (zenodo.org).
T. H. Kim: Seasonal influenza and vaccine herd effect. In: Clinical and Experimental Vaccine Research. 3. Jahrgang, Nr.2, 2014, S.128–132, doi:10.7774/cevr.2014.3.2.128, PMID 25003085, PMC 4083064 (freier Volltext).
A. Lenzi, V. Mirone, V. Gentile, R. Bartoletti, V. Ficarra, C. Foresta, L. Mariani, S. Mazzoli, S. G. Parisi, A. Perino, M. Picardo, C. M. Zotti: Rome Consensus Conference – statement; human papilloma virus diseases in males. In: BMC Public Health. 13. Jahrgang, 2013, S.117, doi:10.1186/1471-2458-13-117, PMID 23391351, PMC 3642007 (freier Volltext).
S. M. Garland, S. R. Skinner, J. M. Brotherton: Adolescent and young adult HPV vaccination in Australia: Achievements and challenges. In: Preventive Medicine. 53 Suppl 1. Jahrgang, 2011, S.S29–35, doi:10.1016/j.ypmed.2011.08.015, PMID 21962468.
F. Njeumi, W. Taylor, A. Diallo, K. Miyagishima, P. P. Pastoret, B. Vallat, M. Traore: The long journey: a brief review of the eradication of rinderpest. In: Revue scientifique et technique. Band 31, Nummer 3, Dezember 2012, S. 729–746, doi:10.20506/rst.31.3.2157, PMID 23520729.
F. Fenner: The global eradication of smallpox. In: Med J Aust., 1980 Mai 17,1(10), S. 455. PMID 7412674
Maia Martcheva u. a.: Vaccine-induced pathogen strain replacement: what are the mechanisms? In: J R Soc Interface, 2008 Jan 6, 5(18), S. 3–13, doi:10.1098/rsif.2007.0236, PMID 17459810, PMC 2405901 (freier Volltext)
Romesa Ibrahim u. a.: Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting. In: Vaccine, 2018 Nov 12; 36(46), S. 7048–7053, doi:10.1016/j.vaccine.2018.09.045, PMID 30297122, PMC 6219892 (freier Volltext)
J. Logan, D. Nederhoff, B. Koch, B. Griffith, J. Wolfson, F. A. Awan, N. E. Basta: What have you HEARD about the HERD? Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate? In: Vaccine. Band 36, Nummer 28, 06 2018, S. 4118–4125, doi:10.1016/j.vaccine.2018.05.037, PMID 29789242, PMC 6008254 (freier Volltext).
K. A. Smith: Smallpox: can we still learn from the journey to eradication? In: The Indian journal of medical research. Band 137, Nummer 5, Mai 2013, S. 895–899, PMID 23760373, PMC 3734679 (freier Volltext).
A. Perisic, C. T. Bauch: Social contact networks and disease eradicability under voluntary vaccination. In: PLoS Computational Biology. 5. Jahrgang, Nr.2, 2009, S.e1000280, doi:10.1371/journal.pcbi.1000280, PMID 19197342, PMC 2625434 (freier Volltext).
F. Fu, D. I. Rosenbloom, L. Wang, M. A. Nowak: Imitation dynamics of vaccination behaviour on social networks. In: Proceedings of the Royal Society B: Biological Sciences. 278. Jahrgang, Nr.1702, 2011, S.42–49, doi:10.1098/rspb.2010.1107, PMID 20667876, PMC 2992723 (freier Volltext) – (harvard.edu [PDF]).
S. Wicker, H. C. Maltezou: Vaccine-preventable diseases in Europe: Where do we stand? In: Expert Review of Vaccines. 13. Jahrgang, Nr.8, 2014, S.979–987, doi:10.1586/14760584.2014.933077, PMID 24958075.
Nisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, Rupert Beale, Nahid Bhadelia: Scientific consensus on the COVID-19 pandemic: we need to act now. In: The Lancet. Band396, Nr.10260, Oktober 2020, ISSN0140-6736, doi:10.1016/s0140-6736(20)32153-x, PMID 33069277, PMC 7557300 (freier Volltext).
Rowena A. Bull, Peter A. White: Mechanisms of GII.4 norovirus evolution. In: Trends in Microbiology. Band19, Nr.5, Mai 2011, ISSN0966-842X, S.233–240, doi:10.1016/j.tim.2011.01.002.
Nisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, Rupert Beale, Nahid Bhadelia: Scientific consensus on the COVID-19 pandemic: we need to act now. In: The Lancet. Band396, Nr.10260, Oktober 2020, ISSN0140-6736, doi:10.1016/s0140-6736(20)32153-x, PMID 33069277, PMC 7557300 (freier Volltext).
Luke Taylor: Covid-19: Is Manaus the final nail in the coffin for natural herd immunity? In: BMJ. 12. Februar 2021, ISSN1756-1833, S.n394, doi:10.1136/bmj.n394 (bmj.com [abgerufen am 23. Februar 2021]).
B. A. Lopman, D. C. Payne, J. E. Tate, M. M. Patel, M. M. Cortese, U. D. Parashar: Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. In: Current Opinion in Virology. 2. Jahrgang, Nr.4, 2012, S.434–442, doi:10.1016/j.coviro.2012.05.002, PMID 22749491 (zenodo.org).
